Research Article
Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study
Table 1
Baseline characteristics of patients with chronic heart failure.
| | Variables | CHF () |
| | Age (years) | 65.25 ± 9.63 | | Male, n (%) | 107 (67.72) | | BMI (kg/m2) | 23.33 ± 2.09 | | IHD, n (%) | 89 (56.33) | | Hypertension, n (%) | 73 (46.20) | | DM, n (%) | 29 (18.35) | | NYHA class, n (%) | | | II/III | 98 (62.03) | | IV | 60 (37.97) | | Medication, n (%) | | | ACE-I/ARB | 140 (88.61) | | Beta-blocker | 132 (83.54) | | Loop diuretic | 118 (74.68) | | Aldosterone antagonist | 70 (44.30) | | Digoxin | 45 (28.48) | | LVEF (%) | 37.82 ± 4.90 | | hs-TnT (pg/ml) | 26.86 ± 9.19 | | hs-CRP (ng/ml) | 3.62 ± 1.08 | | NT-proBNP (pg/ml) | 2043.59 ± 1094.89 |
|
|
Values are mean ± standard deviation or proportions.
|
